PL2882432T3 - Sposób leczenia trądziku - Google Patents

Sposób leczenia trądziku

Info

Publication number
PL2882432T3
PL2882432T3 PL13827298T PL13827298T PL2882432T3 PL 2882432 T3 PL2882432 T3 PL 2882432T3 PL 13827298 T PL13827298 T PL 13827298T PL 13827298 T PL13827298 T PL 13827298T PL 2882432 T3 PL2882432 T3 PL 2882432T3
Authority
PL
Poland
Prior art keywords
acne
treatment
Prior art date
Application number
PL13827298T
Other languages
English (en)
Inventor
Scott Lundahl
Original Assignee
Dusa Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dusa Pharmaceuticals, Inc. filed Critical Dusa Pharmaceuticals, Inc.
Publication of PL2882432T3 publication Critical patent/PL2882432T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13827298T 2012-08-10 2013-08-09 Sposób leczenia trądziku PL2882432T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681888P 2012-08-10 2012-08-10
EP13827298.4A EP2882432B1 (en) 2012-08-10 2013-08-09 Method for the treatment of acne
PCT/US2013/054263 WO2014026077A1 (en) 2012-08-10 2013-08-09 Method for the treatment of acne

Publications (1)

Publication Number Publication Date
PL2882432T3 true PL2882432T3 (pl) 2020-07-13

Family

ID=50066728

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13827298T PL2882432T3 (pl) 2012-08-10 2013-08-09 Sposób leczenia trądziku

Country Status (7)

Country Link
US (2) US9387341B2 (pl)
EP (1) EP2882432B1 (pl)
AU (1) AU2013299487B2 (pl)
CA (1) CA2881439C (pl)
ES (1) ES2778031T3 (pl)
PL (1) PL2882432T3 (pl)
WO (1) WO2014026077A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2882432B1 (en) * 2012-08-10 2020-02-12 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
BR112016014073A2 (pt) 2013-12-20 2017-08-08 Galderma Res & Dev Tratamento fotodinâmico de pulso de pele fotodanificada
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039188A1 (en) * 1995-06-05 1996-12-12 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6223071B1 (en) * 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
CA2422865C (en) 2000-08-16 2012-10-16 The General Hospital Corporation D/B/A Massachusetts General Hospital Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
WO2002062420A1 (en) * 2001-01-22 2002-08-15 SØRENSEN, Svein Photodynamic stimulation device and methods
US7094228B2 (en) * 2001-07-31 2006-08-22 Zars, Inc. Methods and formulations for photodynamic therapy
US7018396B2 (en) * 2001-08-07 2006-03-28 New England Medical Center Hospitals, Inc. Method of treating acne
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
US20070179482A1 (en) * 2004-05-07 2007-08-02 Anderson Robert S Apparatuses and methods to treat biological external tissue
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
EP1871421A1 (en) * 2005-04-07 2008-01-02 Photo Diagnostic Devices (PDD) Ltd Photosensitizers and mri enhancers
GB0608315D0 (en) * 2006-04-27 2006-06-07 Univ St Andrews Light emitting device for use in therapeutic and/or cosmetic treatment
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
WO2009093144A2 (en) * 2008-01-25 2009-07-30 Qlt, Inc.Lau Photodynamic therapy of sebaceous gland disorders
US20090259167A1 (en) * 2008-04-04 2009-10-15 The General Hospital Corporation Methods and compositions for dose-dependent photodynamic therapy of disorders
US20100100083A1 (en) * 2008-10-22 2010-04-22 Scott Lundahl Method of treatment for dermatologic disorders
US8927761B2 (en) * 2012-06-28 2015-01-06 Photocure Asa Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same
EP2882432B1 (en) * 2012-08-10 2020-02-12 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
ES2746293T3 (es) * 2012-08-16 2020-03-05 Dusa Pharmaceuticals Inc Agente fototerapéutico para usar en un método de tratamiento de la onicomicosis
US20140067024A1 (en) * 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp

Also Published As

Publication number Publication date
CA2881439A1 (en) 2014-02-13
EP2882432B1 (en) 2020-02-12
US10029116B2 (en) 2018-07-24
EP2882432A4 (en) 2016-04-06
ES2778031T3 (es) 2020-08-07
US20160317831A1 (en) 2016-11-03
US20140046289A1 (en) 2014-02-13
AU2013299487A1 (en) 2015-02-26
US9387341B2 (en) 2016-07-12
EP2882432A1 (en) 2015-06-17
AU2013299487B2 (en) 2017-02-02
WO2014026077A1 (en) 2014-02-13
CA2881439C (en) 2017-08-29

Similar Documents

Publication Publication Date Title
IL237791A0 (en) A method for treating cancer
SG11201503893RA (en) Method of treating cancer
HK1210962A1 (en) Methods for treatment of atherosclerosis
SG11201504957RA (en) Water treatment method
EP2855366A4 (en) PROCESS FOR TREATING WATER
EP2852559A4 (en) METHOD OF TREATING MUD
HK1202297A1 (en) Methods for treating acne
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
HK1186986A1 (zh) 治療皮膚病的方法
EP2884975A4 (en) METHOD OF TREATING ONYCHOMYCOSIS
EP2849778A4 (en) PROCESS FOR TREATMENT OF INFLAMMATION
EP2816126A4 (en) THERMAL TREATMENT METHOD
GB201205911D0 (en) Hair treatment method
HUE038149T2 (hu) Eljárás acél kezelésére
EP2882432A4 (en) PROCESS FOR TREATING ACNE
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
HK1206649A1 (en) Method of treating acne acne
HK1209040A1 (en) Methods for treating vestibulotoxicity
ZA201407215B (en) Method for emulsion treatment
GB201105523D0 (en) Treatment method
AP2015008271A0 (en) Method for producing an agent for the treatment oftuberculosis
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
AU2012905617A0 (en) Treatment method
AU2012905240A0 (en) Method of Treatment